Latest Abaxis Inc. Stories
UNION CITY, Calif., Nov. 7, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Kenneth Aron, Chief Technology Officer, will present at the Sidoti & Company's New York II Emerging Growth Institutional Investor Forum on Thursday, November 10, 2011 at 1:20 p.m. ET. The conference will be held at the Grand Hyatt New York Hotel in New York City. About Abaxis Abaxis develops, manufactures,...
UNION CITY, Calif., Oct. 25, 2011 /PRNewswire/ -- ABAXIS, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the second fiscal quarter ended September 30, 2011. Record quarterly highlights include: Revenues of $40.0 million, up 13% over last year's comparable quarter.North America revenues of $32.0 million, up 8% over last year's comparable quarter.Veterinary market sales of $31.5 million, up 18% over...
UNION CITY, Calif., Oct. 17, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today its sponsorship of the Kansas State University Foundation to form the Abaxis Clinical Pathology Resident Fund that will provide support for a clinical pathology resident in the College of Veterinary Medicine at Kansas State University. "The formation of the Abaxis Clinical Pathology Resident Fund further exemplifies...
UNION CITY, Calif., Oct. 17, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the second quarter of fiscal year 2012, ended September 30, 2011. The call will be at 4:15 p.m. ET on Tuesday, October 25, 2011. The Company will report financial results for the second quarter of fiscal year 2012 after the market closes on Tuesday, October 25,...
UNION CITY, Calif., Oct. 3, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Abaxis Veterinary Reference Laboratories, (AVRL), based in Olathe, Kansas, and in partnership with Kansas State University, is fully operational and is accepting and processing samples nationwide. With the addition of AVRL, Abaxis now offers veterinarians nationwide a highly competitive full-service commercial...
UNION CITY, Calif., Sept. 13, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the 2011 UBS Global Life Sciences Conference on Tuesday, September 20, 2011 at 10:30 a.m. ET. The conference will be held at the Grand Hyatt New York Hotel in New York City. About Abaxis Abaxis develops, manufactures, markets and sells...
UNION CITY, Calif., Sept. 9, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at CL King's 9th Annual Best Ideas Conference 2011 on Wednesday, September 14, 2011 at 9:00 a.m. ET. The conference will be held at The Omni Berkshire Place Hotel in New York City. About Abaxis Abaxis develops, manufactures, markets and sells...
UNION CITY, Calif., Sept. 8, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Serverson, chief executive officer, will present at 2011 Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 13, 2011 at 10:20 a.m. ET at the Grand Hyatt New York. About Abaxis Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary...
UNION CITY, Calif., Aug. 8, 2011 /PRNewswire/ -- ABAXIS, Inc. (Nasdaq: ABAX) today announced that its Board of Directors has approved the repurchase of up to an aggregate of $40,000,000 of its Common Stock. The repurchases will be made from time to time on the open market at prevailing market prices or in negotiated transactions off the market. Clint Severson, chairman and chief executive officer of Abaxis, commented "We believe that the repurchase program is a good investment of...
CHICAGO, July 29, 2011 /PRNewswire/ -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List - Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): Park Electrochemical Corp. (NYSE: PKE) and Shanda Interactive Entertainment Ltd ADR (Nasdaq: SNDA). Further, Zacks announced #4 Rankings (Sell) on two other widely held stocks: Air Methods Corporation (Nasdaq: AIRM) and Abaxis, Inc. (Nasdaq: ABAX)....
